External used medicines for Hong Kong foot and tinea manuum

A technology for external application of medicine and tinea pedis, applied in the field of topical medicines for treating tinea pedis and tinea pedis, can solve long-term problems, it takes at least 10 days to cure mild patients, at least 30 days to cure severe patients, and the recurrence of tinea pedis and tinea pedis. high rate, to achieve the effect of low recurrence rate and short time

Inactive Publication Date: 2005-02-23
付士强
View PDF0 Cites 8 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

At present, there are many external medicines for treating tinea pedis and tinea manuum on the market, and these medicines for external use take a long time to cure tinea pedis and tinea manuum. I

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0014] 1. Component drugs

[0015] (1), Hibiscus bark: a commercial product of traditional Chinese medicine, (2), Baibu: a commercial product of traditional Chinese medicine, (3), Fructus Cnidii: a commercial product of traditional Chinese medicine, (4), Sophora flavescens: a commercial product of traditional Chinese medicine, ( 5), rhubarb: commercially available traditional Chinese medicine, (6), ethanol: pharmaceutical grade (50% to 95%) ethanol, (7), benzoic acid: commercially available medicinally, (8), diphenhydramine hydrochloride : a commercially available medicinal product, 9), camphor: a commercially available medicinal product.

[0016] 2. The composition formula of the medicine, calculated in parts by weight,

[0017] Hibiscus bark 13 Herba 10 Cnidium 13 Sophora flavescens 10 Rhubarb 13 Ethanol 350

[0018] Benzoic acid 15 Diphenhydramine hydrochloride 6 Camphor 15

[0019] 3. Drug preparation

[0020] (1), after solid benzoic acid, diphenhydramine hydrochlorid...

Embodiment 2

[0061] 1, component medicine is the same as embodiment 1

[0062] 2. The composition formula of the medicine, calculated in parts by weight,

[0063] Hibiscus bark 35 100 parts 18 Cnidium 35 Sophora flavescens 18 Rhubarb 35 Ethanol 480

[0064] Benzoic acid 40 Diphenhydramine hydrochloride 7 Camphor 40

[0065] 3, medicine preparation is the same as embodiment 1

[0066] 4. Clinical application test

[0067] I. Clinical application test of tinea pedis

[0068] (1), the number of cases: 477 cases, male: 203 cases, mild patients: 108 cases, severe patients: 95 cases;

[0069] Female: 274 cases, mild patients: 146 cases, severe patients: 128 cases;

[0070] The age range of patients ranged from 14 to 50 years old.

[0071] (2), symptom is the same as embodiment 1

[0072] (3), method of treatment is the same as embodiment 1

[0073] (4), curative effect evaluation standard is the same as embodiment 1

[0074] (5), treatment results...

Embodiment 3

[0088] 1, component medicine is the same as embodiment 1

[0089] 2. The composition formula of the medicine, calculated in parts by weight,

[0090] Hibiscus bark 50 Baibu 30 Cnidium 50 Sophora flavescens 30 Rhubarb 50 Ethanol 600

[0091] Benzoic acid 60 Diphenhydramine hydrochloride 10 Camphor 60

[0092] 3, medicine preparation is the same as embodiment 1

[0093] 4. Clinical application test

[0094] I. Clinical application test of tinea pedis

[0095] (1) Number of cases: 835 cases, male: 535 cases, mild patients: 380 cases, severe patients: 155 cases;

[0096] Female: 300 cases, mild patients: 203 cases, severe patients: 97 cases;

[0097] The age range of patients ranged from 14 to 50 years old.

[0098] (2), symptom is the same as embodiment 1

[0099] (3), method of treatment is the same as embodiment 1

[0100] (4), curative effect evaluation standard is the same as embodiment 1

[0101] (5), treatment results are sho...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

An exterior-applied medicine in the form of orange suspension for treating tinea manuum and tinea pedis is prepared from 5 Chinese-medicinal materials including stemona root, cnidium fruit, flavescent sophora root, etc through immersing in alcohol, filtering, proportionally mixing with benzoic acid, bagodryl hydrochloride and camphor.

Description

technical field [0001] The invention relates to an external medicine for treating tinea pedis and tinea manuum. Background technique [0002] Tinea pedis and tinea manuum are common skin diseases. At present, there are many external medicines for treating tinea pedis and tinea manuum on the market, and these medicines for external use take a long time to cure tinea pedis and tinea manuum. It takes at least 10 days to cure mild patients, and at least 30 days to cure severe patients. The recurrence rate is high, and more than 70% of patients relapse within 15 to 20 days after being cured. Contents of the invention [0003] The technical problem to be solved by the present invention is to provide a kind of external medicine for treating tinea pedis and tinea manuum which has a short cure time and low recurrence rate after the tinea pedis and tinea manuum are cured. [0004] The medicine for external use of the present invention comprises the following components in parts by...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61P17/00A61P31/10
Inventor 付士强
Owner 付士强
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap